Xact Kapitalforvaltning’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$40.3M Buy
1,302,745
+16,575
+1% +$565K 0.86% 19
2019
Q4
$47.8M Buy
1,286,170
+14,698
+1% +$524K 0.81% 22
2019
Q3
$43.3M Buy
1,271,472
+101,368
+9% +$3.69M 0.82% 24
2019
Q2
$48.1M Buy
1,170,104
+34,724
+3% +$1.38M 0.99% 14
2019
Q1
$45.7M Buy
1,135,380
+1,387
+0.1% +$55.5K 1.03% 14
2018
Q4
$47M Sell
1,133,993
-66,088
-6% -$2.74M 1.21% 9
2018
Q3
$50.2M Sell
1,200,081
-94,838
-7% -$3.65M 1.05% 11
2018
Q2
$44.6M Buy
1,294,919
+59,648
+5% +$2.04M 0.95% 15
2018
Q1
$41.6M Buy
1,235,271
+4,866
+0.4% +$167K 0.94% 14
2017
Q4
$42.3M Buy
1,230,405
+81,461
+7% +$2.78M 1.01% 12
2017
Q3
$38.9M Buy
1,148,944
+12,707
+1% +$408K 1.11% 12
2017
Q2
$36.2M Sell
1,136,237
-9,604
-0.8% -$303K 1.1% 11
2017
Q1
$37.2M Buy
1,145,841
+80,421
+8% +$2.54M 1.15% 11
2016
Q4
$32.8M Buy
1,065,420
+39,427
+4% +$1.2M 1.15% 13
2016
Q3
$33M Buy
+1,025,993
New +$34.3M 1.17% 12

Other funds holding PFE

Xact Kapitalforvaltning's PFE Position: Q1 2020 in Review

Xact Kapitalforvaltning increased its Pfizer (PFE) stake by 1.3% in Q1 2020, buying an estimated $565K and bringing the position to 1,302,745 shares worth $40.3M. The position accounts for 0.86% of the portfolio, ranked #19.

Xact Kapitalforvaltning first reported a position in PFE in Q3 2016 and has held it in 15 quarters since. The position peaked at $50.2M in Q3 2018. 2,438 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • Xact Kapitalforvaltning held 1,302,745 shares of Pfizer worth $40.3M as of Q1 2020.
  • Xact Kapitalforvaltning bought 16,575 Pfizer shares in Q1 2020, an estimated $565K.
  • Pfizer made up 0.86% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #19 holding.
  • Xact Kapitalforvaltning first reported a position in Pfizer in Q3 2016 and has held it in 15 quarters since.
  • Xact Kapitalforvaltning's Pfizer position peaked at $50.2M in Q3 2018.
  • 2,438 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.